TABLE 4.

Hepatic ceramide fatty acid composition in NASH and antioxidant treatment

VitE	Chow		WD for 8 weeks		WD for 20 weeks
	(−)	(+)	(−)	(+)	(−)	(+)
14:0	5.01 ± 0.35	3.00 ± 0.68	2.18 ± 0.64a	4.25 ± 0.57	2.57 ± 0.52a	5.14 ± 0.82
16:0	57.10 ± 1.56	53.55 ± 1.10	54.47 ± 1.89	53.26 ± 0.98	52.54 ± 1.45	57.79 ± 0.93b
18:0	24.95 ± 1.30	29.41 ± 1.10b	29.29 ± 1.32a	28.44 ± 0.97	29.86 ± 0.66a	26.28 ± 0.84b
18:1ω9	12.93 ± 0.81	14.04 ± 1.56	12.78 ± 1.45	13.85 ± 0.89	15.04 ± 0.90	10.79 ± 0.76b

Data are expressed as the mean (percent of lipid composition) ± SEM, n = 8–11 mice.

^aP < 0.05 versus chow.

^bP < 0.05 versus no VitE treatment, same diet.